BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 185 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,030,000 | -34.0% | 18,951 | -36.6% | 0.12% | -28.5% |
| Q3 2021 | $3,074,000 | +73.3% | 29,902 | +48.2% | 0.17% | +81.1% |
| Q2 2021 | $1,774,000 | +7.7% | 20,171 | +19.1% | 0.10% | +1.1% |
| Q1 2021 | $1,647,000 | -3.6% | 16,938 | +11.2% | 0.09% | -23.6% |
| Q4 2020 | $1,709,000 | -42.6% | 15,235 | -52.5% | 0.12% | +26.8% |
| Q3 2020 | $2,975,000 | +1109.3% | 32,096 | +943.1% | 0.10% | +1840.0% |
| Q1 2019 | $246,000 | +22.4% | 3,077 | -2.9% | 0.01% | 0.0% |
| Q2 2018 | $201,000 | -54.9% | 3,170 | -34.8% | 0.01% | -61.5% |
| Q1 2018 | $446,000 | – | 4,863 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
| Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
| Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
| DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
| BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
| Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
| Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
| Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
| Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |